Emerald Cloud Lab vs Cradle
Side-by-side comparison of AI visibility scores, market position, and capabilities
Emerald Cloud Lab offers a fully remote, cloud-controlled laboratory with 200+ instrument models; ~$15M ARR as of 2025 with labs in the U.S. and expanded facilities in Austin and Pittsburgh.
About
Emerald Cloud Lab (ECL) is a biotechnology infrastructure company that enables scientists to conduct real wet-lab experiments entirely remotely through a cloud-based interface. Founded as a spin-out of Emerald Therapeutics, ECL operates physical laboratories stocked with over 200 instrument models — including liquid handlers, mass spectrometers, and genomics tools — that researchers control through its unified Command Center software. Scientists can design, execute, and analyze experiments without ever entering a physical lab, democratizing access to advanced instrumentation that would otherwise require millions in capital expenditure.
AI protein design platform combining language models with lab automation; active learning cycles for enzyme, antibody, and therapeutic protein engineering optimization.
About
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, activity, and manufacturability. Founded in 2021 and headquartered in Amsterdam with teams in San Francisco, Cradle raised approximately $24 million and targets biopharmaceutical, agricultural, and industrial biotechnology companies that need to engineer proteins with specific functional properties.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.